Diabetes Ups Risk of Adverse Outcomes in Chronic Heart Failure

Share this content:
Diabetes Ups Risk of Adverse Outcomes in Chronic Heart Failure
Diabetes Ups Risk of Adverse Outcomes in Chronic Heart Failure

TUESDAY, March 7, 2017 (HealthDay News) -- For outpatients with chronic heart failure, diabetes is associated with increased risk of one-year adverse outcomes, according to a study published online March 2 in Diabetes Care.

Marco Dauriz, M.D., from the University and Azienda Ospedaliera Universitaria Integrata of Verona in Italy, and colleagues examined whether diabetes status independently affects the one-year risk of all-cause and cardiovascular disease (CVD) mortality and first hospitalization for heart failure in a cohort of 9,428 outpatients with chronic heart failure.

The researchers found that patients with diabetes had higher cumulative rates of one-year all-cause death (9.4 versus 7.2 percent; adjusted hazard ratio, 1.28; 95 percent confidence interval, 1.07 to 1.54), CVD death (4.8 versus 3.8 percent; adjusted hazard ratio, 1.28; 95 percent confidence interval, 0.99 to 1.66), and heart failure hospitalization (13.8 versus 9.3 percent; adjusted hazard ratio, 1.37; 95 percent confidence interval, 1.17 to 1.60), compared with those without diabetes, irrespective of confounding variables. There was a significant and independent association between increasing hemoglobin A1c level with the risk of one-year survival outcomes among the 2,567 patients with hemoglobin A1c measurements available at baseline.

"The presence of diabetes markedly increases the risk of one-year adverse clinical outcomes in outpatients with chronic heart failure independent of multiple common risk factors," the authors write. "More effective and personalized treatment for diabetes should be considered in this particularly high-risk patient population."

Several authors disclosed financial ties to the pharmaceutical and medical device industries. Several pharmaceutical companies provided support for the EURObservational Research Program.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »